{"id":987507972,"date":"2025-10-28T13:08:33","date_gmt":"2025-10-28T13:08:33","guid":{"rendered":"https:\/\/hollandcapital.nl\/project\/semalytix\/"},"modified":"2025-10-28T16:51:16","modified_gmt":"2025-10-28T16:51:16","slug":"semalytix","status":"publish","type":"project","link":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/","title":{"rendered":"Semalytix"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#213564&#8243; background_enable_image=&#8220;off&#8220; background_position=&#8220;bottom_center&#8220; background_vertical_offset=&#8220;42%&#8220; background_blend=&#8220;soft-light&#8220; height=&#8220;30vh&#8220; custom_padding=&#8220;||||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#FFFFFF&#8220; min_height=&#8220;1002.2px&#8220; custom_margin=&#8220;||-53px|||&#8220; custom_padding=&#8220;57px||56px||false|&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row column_structure=&#8220;3_5,2_5&#8243; use_custom_gutter=&#8220;on&#8220; gutter_width=&#8220;2&#8243; make_equal=&#8220;on&#8220; custom_padding_last_edited=&#8220;on|tablet&#8220; admin_label=&#8220;Team Section Title  &#8220; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; max_width=&#8220;1350px&#8220; custom_margin=&#8220;|auto|35px|auto|false|false&#8220; custom_padding=&#8220;||10px||false|false&#8220; custom_padding_tablet=&#8220;|||||true&#8220; custom_padding_phone=&#8220;0px||10px||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;3_5&#8243; _builder_version=&#8220;4.17.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220; custom_css_main_element_last_edited=&#8220;on|tablet&#8220; custom_css_main_element_tablet=&#8220;margin-bottom:15px;&#8220; custom_css_main_element_phone=&#8220;margin-bottom:15px;&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato|700|||||||&#8220; text_text_color=&#8220;#243B66&#8243; text_font_size=&#8220;30px&#8220; text_line_height=&#8220;1em&#8220; header_font=&#8220;Lato|700|||||||&#8220; header_font_size=&#8220;33px&#8220; header_2_font=&#8220;Lato|700|||||||&#8220; header_2_text_align=&#8220;center&#8220; header_2_text_color=&#8220;#1a243f&#8220; header_2_font_size=&#8220;33px&#8220; custom_margin=&#8220;||7px||false|false&#8220; custom_margin_tablet=&#8220;&#8220; custom_margin_phone=&#8220;||0px||false|false&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; custom_padding=&#8220;|0px|||false|false&#8220; custom_padding_tablet=&#8220;&#8220; custom_padding_phone=&#8220;|0px||0px|false|false&#8220; custom_padding_last_edited=&#8220;on|phone&#8220; header_font_size_tablet=&#8220;&#8220; header_font_size_phone=&#8220;30px&#8220; header_font_size_last_edited=&#8220;on|phone&#8220; header_2_text_align_tablet=&#8220;&#8220; header_2_text_align_phone=&#8220;left&#8220; header_2_text_align_last_edited=&#8220;on|desktop&#8220; header_2_font_size_tablet=&#8220;&#8220; header_2_font_size_phone=&#8220;30px&#8220; header_2_font_size_last_edited=&#8220;on|phone&#8220; header_2_line_height_tablet=&#8220;&#8220; header_2_line_height_phone=&#8220;34px&#8220; header_2_line_height_last_edited=&#8220;on|phone&#8220; custom_css_main_element=&#8220;width: fit-content;||position: relative;&#8220; custom_css_after=&#8220;position: absolute;||content: &#8220;;||right: 0;||top:40%;||width: 50px;||height: 1px;||background-color: var(&#8211;team-color);transform: translateY(-50%);&#8220; global_colors_info=&#8220;{}&#8220; custom_css_before_last_edited=&#8220;on|phone&#8220; custom_css_before_phone=&#8220;display:none;&#8220; custom_css_after_last_edited=&#8220;on|phone&#8220; custom_css_after_phone=&#8220;display:none;&#8220; header_2_line_height__hover_enabled=&#8220;off|desktop&#8220; custom_css_after_tablet=&#8220;position: absolute;||content: &#8220;;||right: 0;||top:40%;||width: 50px;||height: 1px;||background-color: var(&#8211;team-color);transform: translateY(-50%);&#8220;]<\/p>\n<p>Semalytix<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato||||||||&#8220; text_text_color=&#8220;#B68013&#8243; text_font_size=&#8220;16px&#8220; text_letter_spacing=&#8220;1px&#8220; width=&#8220;70%&#8220; custom_margin=&#8220;||8px||false|false&#8220; custom_margin_tablet=&#8220;||19px||false|false&#8220; custom_margin_phone=&#8220;||16px||false|false&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; custom_padding=&#8220;||1px|||&#8220; custom_css_main_element=&#8220;color:var(&#8211;team-color);&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Semalytix bietet eine Agentic-KI-Plattform f\u00fcr die Pharmaindustrie<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;2_5&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png&#8220; title_text=&#8220;Semalytix&#8220; align=&#8220;right&#8220; align_tablet=&#8220;center&#8220; align_phone=&#8220;center&#8220; align_last_edited=&#8220;on|phone&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; width=&#8220;50%&#8220; custom_margin=&#8220;|-4px|17px|||&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_3,1_3,1_3&#8243; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#EFEFEF&#8220; max_width=&#8220;1350px&#8220; custom_margin=&#8220;|auto||auto|false|false&#8220; custom_padding=&#8220;50px|65px|50px|65px|true|true&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato|700||on|||||&#8220; text_text_color=&#8220;#B68013&#8243; text_font_size=&#8220;16px&#8220; text_letter_spacing=&#8220;1px&#8220; custom_margin=&#8220;||19px||false|false&#8220; custom_margin_tablet=&#8220;||19px||false|false&#8220; custom_margin_phone=&#8220;||16px||false|false&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; custom_padding=&#8220;||1px|||&#8220; custom_css_main_element=&#8220;color:var(&#8211;team-color);&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Einf\u00fchrung<\/p>\n<p>[\/et_pb_text][et_pb_blurb title=&#8220;Im Bestand: Oktober 2025&#8243; image_icon_background_color=&#8220;RGBA(255,255,255,0)&#8220; image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8220; icon_placement=&#8220;left&#8220; image_icon_width=&#8220;45%&#8220; disabled_on=&#8220;off|off|off&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Lato||||||||&#8220; header_text_color=&#8220;#000000&#8243; header_font_size=&#8220;20px&#8220; custom_margin=&#8220;10px||15px||false|false&#8220; custom_css_blurb_title=&#8220;margin-top: -3px;&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_blurb title=&#8220;Gesundheitswesen&#8220; image_icon_background_color=&#8220;RGBA(255,255,255,0)&#8220; image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8220; icon_placement=&#8220;left&#8220; image_icon_width=&#8220;45%&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Lato||||||||&#8220; header_text_color=&#8220;#000000&#8243; header_font_size=&#8220;20px&#8220; custom_margin=&#8220;||15px|||&#8220; custom_css_blurb_title=&#8220;margin-top: -3px;&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_blurb title=&#8220;Venture &#038; Growth&#8220; image_icon_background_color=&#8220;RGBA(255,255,255,0)&#8220; image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8220; icon_placement=&#8220;left&#8220; image_icon_width=&#8220;45%&#8220; disabled_on=&#8220;off|off|off&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Lato||||||||&#8220; header_text_color=&#8220;#000000&#8243; header_font_size=&#8220;20px&#8220; custom_margin=&#8220;||15px|||&#8220; custom_css_blurb_title=&#8220;margin-top: -3px;&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][et_pb_blurb title=&#8220;Add ons&#8220; image_icon_background_color=&#8220;RGBA(255,255,255,0)&#8220; image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8220; icon_placement=&#8220;left&#8220; image_icon_width=&#8220;45%&#8220; disabled_on=&#8220;on|on|on&#8220; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Lato||||||||&#8220; header_text_color=&#8220;#000000&#8243; header_font_size=&#8220;20px&#8220; body_text_color=&#8220;#000000&#8243; custom_margin=&#8220;||-3px|||&#8220; custom_css_blurb_title=&#8220;margin-top: -3px;&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<ul>\n<li>Praktische GGZ<\/li>\n<li>ad Astra<\/li>\n<li>&#8230;<\/li>\n<\/ul>\n<p>[\/et_pb_blurb][et_pb_blurb title=&#8220;semalytix.com&#8220; url=&#8220;https:\/\/semalytix.com\/&#8220; url_new_window=&#8220;on&#8220; image_icon_background_color=&#8220;RGBA(255,255,255,0)&#8220; image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/11\/Molen_blauw_RGB.png&#8220; icon_placement=&#8220;left&#8220; image_icon_width=&#8220;45%&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; header_font=&#8220;Lato||||||||&#8220; header_text_color=&#8220;#000000&#8243; header_font_size=&#8220;20px&#8220; custom_margin=&#8220;||15px|||&#8220; custom_css_blurb_title=&#8220;margin-top: -3px;&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato|700||on|||||&#8220; text_text_color=&#8220;#B68013&#8243; text_font_size=&#8220;16px&#8220; text_letter_spacing=&#8220;1px&#8220; custom_margin=&#8220;||8px||false|false&#8220; custom_margin_tablet=&#8220;||19px||false|false&#8220; custom_margin_phone=&#8220;||16px||false|false&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; custom_padding=&#8220;||1px|||&#8220; custom_css_main_element=&#8220;color:var(&#8211;team-color);&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>\u00dcber Semalytix<\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8220;off|off|off&#8220; module_id=&#8220;module2-css-class&#8220; module_class=&#8220;module2-css-class&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;#000000&#8243; link_text_color=&#8220;#B68013&#8243; header_text_align=&#8220;left&#8220; header_text_color=&#8220;#000000&#8243; text_orientation=&#8220;justified&#8220; custom_margin=&#8220;-2px||||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Die Semalytix GmbH mit Sitz in Bielefeld bietet eine Agentic-KI-Plattform f\u00fcr die Pharmaindustrie. Die auf PatientGPT basierende Atlas-Plattform erm\u00f6glicht Pharma-Teams den regelkonformen Zugriff auf globale Patientenperspektiven sowie den Aufbau, die Implementierung und den Besitz einer stetig wachsenden Bibliothek ma\u00dfgeschneiderter KI-Modelle. Dieses \u201eAgent-as-a-Service\u201c-Modell bef\u00e4higt Unternehmen, Patienteninformationen direkt in ihre Arbeitsabl\u00e4ufe zu integrieren, was eine entscheidende F\u00e4higkeit darstellt, da Sch\u00e4tzungen zufolge 75 bis 85 Prozent der pharmazeutischen Prozesse Aufgaben umfassen, die durch KI-Agenten automatisiert oder erweitert werden k\u00f6nnen. Auf diese Weise k\u00f6nnen Unternehmen kumulatives geistiges Eigentum aufbauen und \u00fcber einmalige Forschungsprojekte hinaus dauerhafte strategische Verm\u00f6genswerte schaffen.    <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_3&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato|700||on|||||&#8220; text_text_color=&#8220;#B68013&#8243; text_font_size=&#8220;16px&#8220; text_letter_spacing=&#8220;1px&#8220; custom_margin=&#8220;||8px||false|false&#8220; custom_margin_tablet=&#8220;||19px||false|false&#8220; custom_margin_phone=&#8220;||16px||false|false&#8220; custom_margin_last_edited=&#8220;on|phone&#8220; custom_padding=&#8220;||1px|||&#8220; custom_css_main_element=&#8220;color:var(&#8211;team-color);&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Warum investieren wir in Semalytix?<\/p>\n<p>[\/et_pb_text][et_pb_text disabled_on=&#8220;off|off|off&#8220; module_id=&#8220;module2-css-class&#8220; module_class=&#8220;module2-css-class&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_text_color=&#8220;#000000&#8243; link_text_color=&#8220;#B68013&#8243; header_text_align=&#8220;left&#8220; header_text_color=&#8220;#000000&#8243; text_orientation=&#8220;justified&#8220; custom_margin=&#8220;-2px||||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p>Jan-Frens van Giessel, Partner Healthcare bei Holland Capital, kommentierte: \u201eSemalytix bedient mit seiner einzigartigen KI-Technologie einen klaren und wachsenden Bedarf im Pharmamarkt. Die Plattform erm\u00f6glicht es, skalierbare Patientenerkenntnisse in Echtzeit zu gewinnen. Wir sind beeindruckt von der starken Marktposition des Unternehmens, seiner technologischen St\u00e4rke und der ambitionierten Vision des Gr\u00fcnderteams. Holland Capital freut sich darauf, Semalytix als Partner zu begleiten und mit unserer Erfahrung den Weg des Unternehmens zu einem globalen Vorreiter im Bereich KI-gest\u00fctzter Patienteneinblicke zu unterst\u00fctzen.\u201c<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8220;https:\/\/hollandcapital.nl\/de\/semalytix-sichert-sich-57-millionen-euro-fuer-die-skalierung-seiner-agentic-ki-plattform\/&#8220; url_new_window=&#8220;on&#8220; button_text=&#8220;Lesen Sie hier die Pressemitteilung&#8220; button_alignment=&#8220;left&#8220; disabled_on=&#8220;off|off|off&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; custom_button=&#8220;on&#8220; button_text_size=&#8220;16px&#8220; button_text_color=&#8220;#213564&#8243; button_bg_color=&#8220;#B68013&#8243; button_border_color=&#8220;RGBA(255,255,255,0)&#8220; button_border_radius=&#8220;3px&#8220; button_font=&#8220;Lato|900|||||||&#8220; button_icon=&#8220;&#xf105;||fa||900&#8243; custom_margin=&#8220;||||false|false&#8220; custom_padding=&#8220;||||false|false&#8220; hover_enabled=&#8220;0&#8243; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220; sticky_enabled=&#8220;0&#8243;][\/et_pb_button][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8220;on|on|on&#8220; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;50px|auto||auto||&#8220; custom_padding=&#8220;||10px|||&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;|900|||||||&#8220; text_text_color=&#8220;#213564&#8243; text_font_size=&#8220;35px&#8220; text_line_height=&#8220;1.1em&#8220; text_orientation=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p style=\"text-align: center;\">Add on<\/p>\n<p>[\/et_pb_text][et_pb_divider color=&#8220;#B68013&#8243; divider_weight=&#8220;4px&#8220; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; transform_translate_linked=&#8220;off&#8220; width=&#8220;11%&#8220; module_alignment=&#8220;center&#8220; custom_margin=&#8220;-10px||||false|false&#8220; custom_padding=&#8220;0px||||false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_5,1_5,1_5,1_5,1_5&#8243; use_custom_gutter=&#8220;on&#8220; gutter_width=&#8220;4&#8243; disabled_on=&#8220;on|on|on&#8220; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; width_tablet=&#8220;&#8220; width_phone=&#8220;50%&#8220; width_last_edited=&#8220;on|phone&#8220; module_alignment=&#8220;center&#8220; min_height=&#8220;91.3px&#8220; custom_padding=&#8220;2px||50px|||&#8220; border_color_all=&#8220;#B68013&#8243; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/01\/logo-02.jpeg&#8220; title_text=&#8220;logo-02&#8243; url=&#8220;https:\/\/www.unpri.org\/&#8220; url_new_window=&#8220;on&#8220; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; width=&#8220;75%&#8220; module_alignment=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/01\/logo-04.jpeg&#8220; title_text=&#8220;logo-04&#8243; url=&#8220;https:\/\/nvp.nl\/&#8220; url_new_window=&#8220;on&#8220; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; width=&#8220;75%&#8220; module_alignment=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/10\/logo_BVK.png&#8220; title_text=&#8220;logo_BVK&#8220; url=&#8220;https:\/\/www.bvkap.de\/home.html&#8220; url_new_window=&#8220;on&#8220; align=&#8220;center&#8220; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/03\/3104587_1626073087104@1182&#215;1182-e1679564489848.jpeg&#8220; title_text=&#8220;3104587_1626073087104@1182&#215;1182&#8243; url=&#8220;https:\/\/nlcares.nl\/nl\/&#8220; url_new_window=&#8220;on&#8220; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; width=&#8220;86%&#8220; module_alignment=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/03\/IMCweekend_metstichting-02_EPS_kopie.jpg&#8220; title_text=&#8220;IMCweekend_metstichting-02_EPS_kopie&#8220; url=&#8220;https:\/\/www.imcweekendschool.nl\/&#8220; url_new_window=&#8220;on&#8220; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#FFFFFF&#8220; custom_margin=&#8220;0px||||false|false&#8220; custom_padding=&#8220;4px||100px||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;11px|auto||auto|false|false&#8220; custom_padding=&#8220;2px||0px|||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato|900|||||||&#8220; text_text_color=&#8220;#283583&#8243; text_font_size=&#8220;30px&#8220; text_line_height=&#8220;1.1em&#8220; custom_padding=&#8220;||0px|||&#8220; animation_direction=&#8220;bottom&#8220; text_font_size_tablet=&#8220;40px&#8220; text_font_size_phone=&#8220;24px&#8220; text_font_size_last_edited=&#8220;on|phone&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p style=\"text-align: center;\"><em>&#8222;<strong>\u201eWir freuen uns sehr, Holland Capital als neuen Partner begr\u00fc\u00dfen zu d\u00fcrfen. Ihre umfassende Expertise in der Skalierung von Technologie- und Gesundheitsunternehmen, die sich in ihrer nachgewiesenen Erfolgsbilanz, darunter der k\u00fcrzlich erfolgte erfolgreiche Verkauf von HealthConnected an Visma, widerspiegelt, wird in Verbindung mit ihrem starken Netzwerk von unsch\u00e4tzbarem Wert sein, wenn wir in unsere n\u00e4chste Phase des beschleunigten Wachstums eintreten. Dar\u00fcber hinaus sind wir au\u00dferordentlich dankbar f\u00fcr das anhaltende Vertrauen und die Unterst\u00fctzung unserer bestehenden Investoren.\u201c  <\/strong><\/em><\/p>\n<p style=\"text-align: center;\"><strong>Janik Jaskolski, MSc, Mitgr\u00fcnder und CEO von Semalytix<\/strong><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_2,1_2&#8243; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;50px|auto||auto|false|false&#8220; custom_padding=&#8220;||0px|||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; background_image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-website-2.png&#8220; height=&#8220;35vh&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_2&#8243; _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; background_image=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix-1.png&#8220; background_position=&#8220;top_center&#8220; background_vertical_offset=&#8220;27%&#8220; height=&#8220;35vh&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; admin_label=&#8220;Sectie&#8220; module_id=&#8220;content&#8220; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#EFEFEF&#8220; custom_padding=&#8220;100px|0px|100px||false|false&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_padding=&#8220;0px||0px|||&#8220; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;|900|||||||&#8220; text_text_color=&#8220;#213564&#8243; text_font_size=&#8220;35px&#8220; text_line_height=&#8220;1.1em&#8220; text_orientation=&#8220;center&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p style=\"text-align: center;\">Gesundheitswesen portfolio<\/p>\n<p>[\/et_pb_text][et_pb_divider color=&#8220;#B68013&#8243; divider_weight=&#8220;4px&#8220; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; transform_translate_linked=&#8220;off&#8220; width=&#8220;11%&#8220; module_alignment=&#8220;center&#8220; custom_margin=&#8220;-10px||||false|false&#8220; custom_padding=&#8220;0px||||false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;-8px|auto||auto|false|false&#8220; custom_padding=&#8220;6px||0px|||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;4_4&#8243; _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_portfolio fullwidth=&#8220;off&#8220; posts_number=&#8220;4&#8243; include_categories=&#8220;43&#8243; show_title=&#8220;off&#8220; show_categories=&#8220;off&#8220; show_pagination=&#8220;off&#8220; zoom_icon_color=&#8220;RGBA(255,255,255,0)&#8220; hover_overlay_color=&#8220;RGBA(255,255,255,0)&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;||-60px||false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_portfolio][et_pb_button button_url=&#8220;https:\/\/hollandcapital.nl\/de\/portfolio\/&#8220; button_text=&#8220;ALLE INVESTITIONEN&#8220; button_alignment=&#8220;center&#8220; _builder_version=&#8220;4.27.4&#8243; _module_preset=&#8220;default&#8220; custom_button=&#8220;on&#8220; button_text_size=&#8220;16px&#8220; button_text_color=&#8220;#FFFFFF&#8220; button_bg_color=&#8220;#B68013&#8243; button_border_color=&#8220;RGBA(255,255,255,0)&#8220; button_border_radius=&#8220;3px&#8220; button_font=&#8220;Lato|900|||||||&#8220; button_icon=&#8220;&#xf105;||fa||900&#8243; custom_margin=&#8220;55px||||false|false&#8220; custom_padding=&#8220;||||false|false&#8220; hover_enabled=&#8220;0&#8243; locked=&#8220;off&#8220; global_colors_info=&#8220;{}&#8220; sticky_enabled=&#8220;0&#8243;][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8220;1&#8243; _builder_version=&#8220;4.25.1&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#213564&#8243; custom_margin=&#8220;||||false|false&#8220; custom_padding=&#8220;60px||29px||false|false&#8220; saved_tabs=&#8220;all&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_row column_structure=&#8220;1_5,1_5,1_5,1_5,1_5&#8243; make_equal=&#8220;on&#8220; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;|auto|6px|auto||&#8220; custom_padding=&#8220;0px||0px|||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_image src=&#8220;https:\/\/hollandcapital.nl\/wp-content\/uploads\/2022\/11\/Holland-capital-logo-wit.png&#8220; title_text=&#8220;Holland capital logo-wit&#8220; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; transform_translate_linked=&#8220;off&#8220; width=&#8220;91%&#8220; custom_margin=&#8220;||||false|false&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_css_main_element=&#8220;margin:auto;&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_css_main_element=&#8220;margin:auto;&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_social_media_follow use_icon_font_size=&#8220;on&#8220; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_button=&#8220;on&#8220; button_text_size=&#8220;16px&#8220; button_text_color=&#8220;#283583&#8243; button_bg_color=&#8220;#FFFFFF&#8220; button_border_color=&#8220;#FFFFFF&#8220; button_font=&#8220;|600|||||||&#8220; button_custom_margin=&#8220;||||false|false&#8220; button_custom_padding=&#8220;||||false|false&#8220; text_orientation=&#8220;left&#8220; background_layout=&#8220;dark&#8220; custom_margin=&#8220;||7px||false|false&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_social_media_follow_network social_network=&#8220;linkedin&#8220; url=&#8220;https:\/\/www.linkedin.com\/company\/hollandcapital\/&#8220; icon_color=&#8220;#283583&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; background_color=&#8220;#FFFFFF&#8220; background_enable_color=&#8220;on&#8220; global_colors_info=&#8220;{}&#8220; follow_button=&#8220;off&#8220; url_new_window=&#8220;on&#8220;]LinkedIn[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8220;1_5,1_5,1_5,1_5,1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; custom_margin=&#8220;|auto|6px|auto||&#8220; custom_padding=&#8220;22px||6px|||&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato||||||||&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;16px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>Amsterdam<\/strong><\/span><br \/>Krijn Taconiskade 426<br \/>1087 HW Amsterdam<br \/>+31 (0) 20 3119411<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.25.1&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato||||||||&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;16px&#8220; global_colors_info=&#8220;{}&#8220;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>D\u00fcsseldorf<\/strong><\/span><br \/><span>Inselstra\u00dfe 34<\/span><br \/><span>40479<\/span> D\u00fcsseldorf<br \/>+49 (0) 211 96290120<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.23&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato||||||||&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;16px&#8220; link_text_color=&#8220;#FFFFFF&#8220; global_colors_info=&#8220;{}&#8220; link_text_color__hover_enabled=&#8220;on|hover&#8220; link_text_color__hover=&#8220;#B68013&#8243;]<\/p>\n<p><span style=\"color: #b68013;\"><strong>Contact<\/strong><\/span><br \/><a href=\"mailto:info@hollandcapital.nl\">info@hollandcapital.de<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][\/et_pb_column][et_pb_column type=&#8220;1_5&#8243; _builder_version=&#8220;4.18.1&#8243; _module_preset=&#8220;default&#8220; global_colors_info=&#8220;{}&#8220;][et_pb_text _builder_version=&#8220;4.20.4&#8243; _module_preset=&#8220;default&#8220; text_font=&#8220;Lato||||||||solid&#8220; text_text_color=&#8220;#FFFFFF&#8220; text_font_size=&#8220;16px&#8220; link_text_color=&#8220;#FFFFFF&#8220; custom_margin=&#8220;1px||||false|false&#8220; global_colors_info=&#8220;{}&#8220; link_text_color__hover_enabled=&#8220;on|hover&#8220; link_text_color__hover=&#8220;#B68013&#8243;]<\/p>\n<p style=\"text-align: left;\"><a href=\"https:\/\/hollandcapital.nl\/de\/privacy-verklaring\/\"><span>Privacy statement<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SemalytixSemalytix bietet eine Agentic-KI-Plattform f\u00fcr die PharmaindustrieEinf\u00fchrung Praktische GGZ ad Astra &#8230; \u00dcber SemalytixDie Semalytix GmbH mit Sitz in Bielefeld bietet eine Agentic-KI-Plattform f\u00fcr die Pharmaindustrie. Die auf PatientGPT basierende Atlas-Plattform erm\u00f6glicht Pharma-Teams den regelkonformen Zugriff auf globale Patientenperspektiven sowie den Aufbau, die Implementierung und den Besitz einer stetig wachsenden Bibliothek ma\u00dfgeschneiderter KI-Modelle. Dieses \u201eAgent-as-a-Service\u201c-Modell bef\u00e4higt Unternehmen, Patienteninformationen direkt in ihre Arbeitsabl\u00e4ufe zu integrieren, was eine entscheidende F\u00e4higkeit darstellt, da Sch\u00e4tzungen zufolge 75 bis 85 Prozent der pharmazeutischen Prozesse Aufgaben umfassen, die durch KI-Agenten automatisiert oder erweitert werden k\u00f6nnen. Auf diese Weise k\u00f6nnen Unternehmen kumulatives geistiges Eigentum aufbauen und \u00fcber einmalige Forschungsprojekte hinaus dauerhafte strategische Verm\u00f6genswerte schaffen. Warum investieren wir in Semalytix?Jan-Frens van Giessel, Partner Healthcare bei Holland Capital, kommentierte: \u201eSemalytix bedient mit seiner einzigartigen KI-Technologie einen klaren und wachsenden Bedarf im Pharmamarkt. Die Plattform erm\u00f6glicht es, skalierbare Patientenerkenntnisse in Echtzeit zu gewinnen. Wir sind beeindruckt von der starken Marktposition des Unternehmens, seiner technologischen St\u00e4rke und der ambitionierten Vision des Gr\u00fcnderteams. Holland Capital freut sich darauf, Semalytix als Partner zu begleiten und mit unserer Erfahrung den Weg des Unternehmens zu einem globalen Vorreiter im Bereich KI-gest\u00fctzter Patienteneinblicke zu unterst\u00fctzen.\u201cAdd on&#8220;\u201eWir freuen uns sehr, Holland Capital als neuen Partner begr\u00fc\u00dfen zu [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":987507917,"comment_status":"open","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"project_category":[87,86],"project_tag":[],"class_list":["post-987507972","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-gesundheitswesen","project_category-venture-growth-de-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.6 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Semalytix \u2013 Portfoliounternehmen von Holland Capital<\/title>\n<meta name=\"description\" content=\"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semalytix\" \/>\n<meta property=\"og:description\" content=\"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/\" \/>\n<meta property=\"og:site_name\" content=\"Holland Capital\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.linkedin.com\/company\/hollandcapital\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T16:51:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png\" \/>\n\t<meta property=\"og:image:width\" content=\"320\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"16\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/\",\"name\":\"Semalytix \u2013 Portfoliounternehmen von Holland Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"datePublished\":\"2025-10-28T13:08:33+00:00\",\"dateModified\":\"2025-10-28T16:51:16+00:00\",\"description\":\"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Semalytix.png\",\"width\":320,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/project\\\/semalytix\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projecten\",\"item\":\"https:\\\/\\\/hollandcapital.nl\\\/project\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Semalytix\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#website\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"name\":\"Holland Capital\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hollandcapital.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#organization\",\"name\":\"Holland Capital Management BV\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"contentUrl\":\"https:\\\/\\\/hollandcapital.nl\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/HC_logo_handtekening.png\",\"width\":186,\"height\":65,\"caption\":\"Holland Capital Management BV\"},\"image\":{\"@id\":\"https:\\\/\\\/hollandcapital.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandcapital\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Semalytix \u2013 Portfoliounternehmen von Holland Capital","description":"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/","og_locale":"de_DE","og_type":"article","og_title":"Semalytix","og_description":"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups","og_url":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/","og_site_name":"Holland Capital","article_publisher":"https:\/\/www.linkedin.com\/company\/hollandcapital\/","article_modified_time":"2025-10-28T16:51:16+00:00","og_image":[{"width":320,"height":200,"url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"16\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/","url":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/","name":"Semalytix \u2013 Portfoliounternehmen von Holland Capital","isPartOf":{"@id":"https:\/\/hollandcapital.nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/#primaryimage"},"image":{"@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/#primaryimage"},"thumbnailUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","datePublished":"2025-10-28T13:08:33+00:00","dateModified":"2025-10-28T16:51:16+00:00","description":"Semalytix ist ein Portfoliounternehmen von Holland Capital. Venture and Growth - Healthcare - Wachstumsfinanzierung - Investitionen in Scale-ups","breadcrumb":{"@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hollandcapital.nl\/de\/project\/semalytix\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/#primaryimage","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2025\/10\/Semalytix.png","width":320,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/hollandcapital.nl\/de\/project\/semalytix\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hollandcapital.nl\/de\/"},{"@type":"ListItem","position":2,"name":"Projecten","item":"https:\/\/hollandcapital.nl\/project\/"},{"@type":"ListItem","position":3,"name":"Semalytix"}]},{"@type":"WebSite","@id":"https:\/\/hollandcapital.nl\/#website","url":"https:\/\/hollandcapital.nl\/","name":"Holland Capital","description":"","publisher":{"@id":"https:\/\/hollandcapital.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hollandcapital.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/hollandcapital.nl\/#organization","name":"Holland Capital Management BV","url":"https:\/\/hollandcapital.nl\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/","url":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","contentUrl":"https:\/\/hollandcapital.nl\/wp-content\/uploads\/2023\/06\/HC_logo_handtekening.png","width":186,"height":65,"caption":"Holland Capital Management BV"},"image":{"@id":"https:\/\/hollandcapital.nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/hollandcapital\/"]}]}},"_links":{"self":[{"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project\/987507972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/comments?post=987507972"}],"version-history":[{"count":2,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project\/987507972\/revisions"}],"predecessor-version":[{"id":987507974,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project\/987507972\/revisions\/987507974"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/media\/987507917"}],"wp:attachment":[{"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/media?parent=987507972"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project_category?post=987507972"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/hollandcapital.nl\/de\/wp-json\/wp\/v2\/project_tag?post=987507972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}